Skip to main content
. 2020 Jan 27;5(1):17. doi: 10.3390/tropicalmed5010017

Figure 4.

Figure 4

Locations of the 10 sites involved in the phase II/III clinical trials of fexinidazole led by the director of Le Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA). Inset: the Isangi clinical site along the Congo river in Democratic Republic of Congo.